bluuebunny/crossref_metadata_2025_split huggingface dataset:
Risk of not being in employment, education or training (NEET) in late adolescence is signalled by school readiness measures at 4–5 years
Authors: Warburton Matthew , Wood Megan L. , Sohal Kuldeep , Wright John , Mon-Williams Mark , Atkinson Amy L. 
Published: May 2024

Abstract
Background
Not being in employment, education, or training (NEET) is associated with poor health (physical and mental) and social exclusion. We investigated whether England’s statutory school readiness measure conducted at 4–5 years provides a risk signal for NEET in late adolescence.

Methods
We identified 8,118 individuals with school readiness measures at 4–5 years and NEET records at 16–17 years using Connected Bradford, a bank of linked routinely collected datasets. Children were categorised as ‘school ready’ if they reached a ‘Good Level of Development’ on the Early Years Foundation Stage Profile. We used probit regression and structural equation modelling to investigate the relationship between school readiness and NEET status and whether it primarily relates to academic attainment.

Results
School readiness was significantly associated with NEET status. A larger proportion of young people who were not school ready were later NEET (11%) compared to those who were school ready (4%). Most of this effect was attributable to shared relationships with academic attainment, but there was also a direct effect. Measures of deprivation and Special Educational Needs were also strong predictors of NEET status.

Conclusions
NEET risk factors occur early in life. School readiness measures could be used as early indicators of risk, with interventions targeted to prevent the long-term physical and mental health problems associated with NEET, especially in disadvantaged areas. Primary schools are therefore well placed to be public health partners in early intervention strategies.
Patterns of care at the end of life: a retrospective study of Italian patients with advanced breast cancer
Authors: Giannubilo Irene , Battistuzzi Linda , Blondeaux Eva , Ruelle Tommaso , Poggio Francesca Benedetta , Buzzatti Giulia , D’Alonzo Alessia , Della Rovere Federica , Latocca Maria Maddalena , Molinelli Chiara , Razeti Maria Grazia , Nardin Simone , Arecco Luca , Perachino Marta , Favero Diletta , Borea Roberto , Pronzato Paolo , Del Mastro Lucia , Bighin Claudia 
Published: May 2024

Abstract
Objectives
To better understand the type of care offered to Italian patients with advanced breast cancer at the End-of-Life (EoL), we conducted a retrospective observational study. EoL was defined as the period of six months before death.

Methods
One hundred and twenty-one patients with advanced breast cancer (ABC) treated at IRCCS San Martino Policlinic Hospital who died between 2017 and 2021 were included. Data about patient, disease, and treatment characteristics from breast cancer diagnosis to death, along with information about comorbidities, medications, imaging, specialist evaluations, hospitalization, palliative care and home care, hospice admissions, and site of death were collected.

Results
98.3% of the patients received at least one line of active treatment at EoL; 52.8% were hospitalized during the selected period. Palliative (13.9%), psychological (7.4%), and nutritional evaluations (8.2%) were underutilized. Palliative home care was provided to 52% of the patients. Most of the patients died at home (66.1%) and fewer than one out of five (18.2%) died at the hospital. Among the patients who died at home, 27.3% had no palliative support.

Conclusions
Our findings indicate that palliative care in EoL breast cancer patients is still inadequate. Only a minority of patients had psychological and nutritional support While low nutritional support may be explained by the fact that typical symptoms of ABC do not involve the gastrointestinal tract, the lack of psychological support suggests that significant barriers still exist. Data on the site of death are encouraging, indicating that EoL management is increasingly home centered in Italy.
Investigating spiritual care perceptions and religious coping methods among the relatives of terminally ill patients during the COVID-19 pandemic: the case of Turkey
Authors: Cetın Zuhal , Ozen Betul 
Published: May 2024

Abstract
Background
The COVID-19 pandemic in Turkey and around the world has had a profound impact on the families of terminally ill patients. In this challenging period, investigating the spiritual care perceptions and religious coping methods of patients' relatives is an essential step towards understanding the experiences in this process with the additional challenges brought by the pandemic and developing appropriate support services. This study aims to determine the spiritual care perceptions and the use of religious coping methods among the relatives of terminally ill patients in Turkey during the COVID-19 pandemic.

Methods
The sample of this descriptive and correlational study consisted of the relatives of terminally ill patients (n = 147) who were receiving treatment in the Anesthesiology and Reanimation Intensive Care Unit of a state hospital in Turkey. Spirituality and Spiritual Care Rating Scale and the Religious Coping Scale to them using face-to-face interviews. Mann–Whitney U test, Kruskal–Wallis test, and Spearman's correlation analysis were used to analyze the data.

Results
The mean age of the participants was 38.84 ± 11.19 years. Also, 63.3% of them were employed. The participant's total score on the Spirituality and Spiritual Care Rating Scale was 57.16 ± 6.41, and it was determined that the participants' level of perception of spirituality and spiritual care concepts was close to good. When the Religious Coping Scale scores of the participants were examined, it was found that both Positive Religious Coping levels (23.11 ± 2.34) and Negative Religious Coping levels (9.48 ± 1.47) were close to high. There was no correlation between the scores of RCOPE and SSCRS (p > 0.05).

Conclusion
As a result, it was determined that the level of perception of spirituality and spiritual care concepts of the relatives of terminally ill patients during the COVID-19 pandemic was close to sound, and their Positive Religious Coping levels were high. Epidemics are a reality of the world, and it is essential to learn lessons from this process and take precautions for the future. We offer a perspective to realize the coping power of religion and spirituality, which are integral parts of life. The needs of terminally ill patients' relatives, a sensitive group, become visible.
Effects of Satureja Khuzestanica supplementation on glycemic indices and lipid profile in type 2 diabetes patients: a randomized controlled clinical-trial
Authors: Roosta Sajjad , Ghasemi Fatemeh , Mokhayeri Yaser , Choobkar Saeed , Nikbakht Mohammad Reza , Falahi Ebrahim 
Published: May 2024

Abstract
Background
Several studies showed the hypoglycemic and hypolipidemic effects of Satureja Khuzestanica (SK) in animal models. This study aimed to determine the effect of SK supplementation on glycemic and lipid outcomes of patients with type 2 diabetes mellitus (T2DM).

Methods
The study was designed as a double-blind, placebo-controlled, randomized clinical trial using block randomization. Seventy-eight T2DM patients were randomly assigned to intervention (n = 39) or placebo (n = 39) groups. They received SK or placebo in 500 mg capsules daily for 12 weeks. Anthropometric, blood pressure, liver enzymes, glycemic, and lipid outcomes were measured before and after the intervention.

Results
At baseline, there were no significant differences in age, sex, or glycated hemoglobin (HbA1c) levels between the groups. SK supplementation led to a significant decrease in FBS (-12.6 ± 20.7 mg/dl in the intervention group versus 3.5 ± 31.9 mg/dl; p = 0.007), HbA1c (-0.28 ± 0.45 in the intervention group versus 0.11 ± 0.54% in the placebo group; p = < 0.001), insulin (-1.65 ± 6.18 in the intervention group versus 2.09 ± 5.90 mIU/L in the placebo group; p = 0.03), total cholesterol (-14.6 ± 21.1 mg/dl in the intervention group versus 8.2 ± 30.9 mg/dl in the placebo group; p < 0.001), LDL-cholesterol (-4.6 ± 15.2 mg/dl in the intervention group versus 5.8 ± 14.6 mg/dl in placebo group; p < 0.001) levels, and significant increase in HDL-cholesterol (3.9 ± 4.9 mg/dl in the intervention group versus 0.9 ± 5.2 mg/dl in placebo group; p = 0.005).

Conclusion
Based on the study results, SK supplementation may improve glycemic indices and lipid profile of patients with T2DM. Our findings may provide novel complementary treatments without adverse effects for diabetes complications. These results need to be further confirmed in clinical trials.

Registration
: This trial has been registered in the Iranian Registry of Clinical Trials (IRCT ID: IRCT20190715044214N1, registration date: 21/02/2021).
Standing together at the helm – how employees experience employee-driven innovation in primary care
Authors: Samuelson Sarah , Pennbrant Sandra , Svensson Ann , Svenningsson Irene 
Published: May 2024

AbstractPrimary care needs to find strategies to deal with today’s societal challenges and continue to deliver efficient and high-quality care. Employee-driven innovation is increasingly gaining ground as an accessible pathway to developing successful and sustainable organisations. This type of innovation is characterised by employees being engaged in the innovation process, based on a bottom-up approach. This qualitative study explores employees’ experiences of employee-driven innovation at a primary care centre in Sweden. Data are collected by focus group interviews and analysed by inductive qualitative content analysis. The result is presented with the overarching theme “Standing together at the helm” followed by three categories: “Motivating factors for practising employee-driven innovation”, “Challenges in practising employee-driven innovation” and “Benefits of employee-driven innovation”, including nine subcategories. The study found that employee-driven innovation fosters organisational innovation, empowers employees, and enhances adaptability at personal and organisational levels. This enables individual and collective learning, and facilitates the shaping, development, and adaptation of working methods to meet internal and external requirements. However, new employees encountered difficulty grasping the concept of employee-driven innovation and recognising its long-term advantages. Additionally, the demanding and task-focused environment within primary care posed challenges in sustaining efforts in innovation work. The employees also experienced a lack of external support to drive and implement some innovative ideas.
Recombinant multiepitope proteins expressed in Escherichia coli cells and their potential for immunodiagnosis
Authors: Gonçalves Ana Alice Maia , Ribeiro Anna Julia , Resende Carlos Ananias Aparecido , Couto Carolina Alves Petit , Gandra Isadora Braga , dos Santos Barcelos Isabelle Caroline , da Silva Jonatas Oliveira , Machado Juliana Martins , Silva Kamila Alves , Silva Líria Souza , dos Santos Michelli , da Silva Lopes Lucas , de Faria Mariana Teixeira , Pereira Sabrina Paula , Xavier Sandra Rodrigues , Aragão Matheus Motta , Candida-Puma Mayron Antonio , de Oliveira Izadora Cristina Moreira , Souza Amanda Araujo , Nogueira Lais Moreira , da Paz Mariana Campos , Coelho Eduardo Antônio Ferraz , Giunchetti Rodolfo Cordeiro , de Freitas Sonia Maria , Chávez-Fumagalli Miguel Angel , Nagem Ronaldo Alves Pinto , Galdino Alexsandro Sobreira 
Published: May 2024

AbstractRecombinant multiepitope proteins (RMPs) are a promising alternative for application in diagnostic tests and, given their wide application in the most diverse diseases, this review article aims to survey the use of these antigens for diagnosis, as well as discuss the main points surrounding these antigens. RMPs usually consisting of linear, immunodominant, and phylogenetically conserved epitopes, has been applied in the experimental diagnosis of various human and animal diseases, such as leishmaniasis, brucellosis, cysticercosis, Chagas disease, hepatitis, leptospirosis, leprosy, filariasis, schistosomiasis, dengue, and COVID-19. The synthetic genes for these epitopes are joined to code a single RMP, either with spacers or fused, with different biochemical properties. The epitopes’ high density within the RMPs contributes to a high degree of sensitivity and specificity. The RMPs can also sidestep the need for multiple peptide synthesis or multiple recombinant proteins, reducing costs and enhancing the standardization conditions for immunoassays. Methods such as bioinformatics and circular dichroism have been widely applied in the development of new RMPs, helping to guide their construction and better understand their structure. Several RMPs have been expressed, mainly using theEscherichia coliexpression system, highlighting the importance of these cells in the biotechnological field. In fact, technological advances in this area, offering a wide range of different strains to be used, make these cells the most widely used expression platform. RMPs have been experimentally used to diagnose a broad range of illnesses in the laboratory, suggesting they could also be useful for accurate diagnoses commercially. On this point, the RMP method offers a tempting substitute for the production of promising antigens used to assemble commercial diagnostic kits.
Mild therapeutic hypothermia upregulates the O-GlcNAcylation level of COX10 to alleviate mitochondrial damage induced by myocardial ischemia–reperfusion injury
Authors: Deng Wei , Chen Yixuan , Zhang Jing , Ling Jitao , Xu Zhou , Zhu Zicheng , Tang Xiaoyi , Liu Xiao , Zhang Deju , Zhu Hong , Lang Haili , Zhang Lieliang , Hua Fuzhou , Yu Shuchun , Qian Kejian , Yu Peng 
Published: May 2024

Abstract
Objective
Mild therapeutic hypothermia (MTH) is an important method for perioperative prevention and treatment of myocardial ischemia–reperfusion injury (MIRI). Modifying mitochondrial proteins after protein translation to regulate mitochondrial function is one of the mechanisms for improving myocardial ischemia–reperfusion injury. This study investigated the relationship between shallow hypothermia treatment improving myocardial ischemia–reperfusion injury and the O-GlcNAcylation level of COX10.

Methods
We used in vivo Langendorff model and in vitro hypoxia/reoxygenation (H/R) cell model to investigate the effects of MTH on myocardial ischemia–reperfusion injury. Histological changes, myocardial enzymes, oxidative stress, and mitochondrial structure/function were assessed. Mechanistic studies involved various molecular biology methods such as ELISA, immunoprecipitation (IP), WB, and immunofluorescence.

Results
Our research results indicate that MTH upregulates the O-GlcNACylation level of COX10, improves mitochondrial function, and inhibits the expression of ROS to improve myocardial ischemia–reperfusion injury. In vivo, MTH effectively alleviates ischemia–reperfusion induced cardiac dysfunction, myocardial injury, mitochondrial damage, and redox imbalance. In vitro, the OGT inhibitor ALX inhibits the OGT mediated O-GlcNA acylation signaling pathway, downregulates the O-Glc acylation level of COX10, promotes ROS release, and counteracts the protective effect of MTH. On the contrary, the OGA inhibitor ThG showed opposite effects to ALX, further confirming that MTH activated the OGT mediated O-GlcNAcylation signaling pathway to exert cardioprotective effects.

Conclusions
In summary, MTH activates OGT mediated O-glycosylation modified COX10 to regulate mitochondrial function and improve myocardial ischemia–reperfusion injury, which provides important theoretical basis for the clinical application of MTH.
Assessing the impact of early progressive mobilization on moderate-to-severe traumatic brain injury: a randomized controlled trial
Authors: Yen Hsiao-Ching , Chuang Hung-Jui , Hsiao Wei-Ling , Tsai Yun-Chen , Hsu Po-Min , Chen Wen-Shiang , Han Yin-Yi 
Published: May 2024

Abstract
Introduction
Traumatic brain injury (TBI) is a major cause of neurodisability worldwide, with notably high disability rates among moderately severe TBI cases. Extensive previous research emphasizes the critical need for early initiation of rehabilitation interventions for these cases. However, the optimal timing and methodology of early mobilization in TBI remain to be conclusively determined. Therefore, we explored the impact of early progressive mobilization (EPM) protocols on the functional outcomes of ICU-admitted patients with moderate to severe TBI.

Methods
This randomized controlled trial was conducted at a trauma ICU of a medical center; 65 patients were randomly assigned to either the EPM group or the early progressive upright positioning (EPUP) group. The EPM group received early out-of-bed mobilization therapy within seven days after injury, while the EPUP group underwent early in-bed upright position rehabilitation. The primary outcome was the Perme ICU Mobility Score and secondary outcomes included Functional Independence Measure motor domain (FIM-motor) score, phase angle (PhA), skeletal muscle index (SMI), the length of stay in the intensive care unit (ICU), and duration of ventilation.

Results
Among 65 randomized patients, 33 were assigned to EPM and 32 to EPUP group. The EPM group significantly outperformed the EPUP group in the Perme ICU Mobility and FIM-motor scores, with a notably shorter ICU stay by 5.9 days (p < 0.001) and ventilation duration by 6.7 days (p = 0.001). However, no significant differences were observed in PhAs.

Conclusion
The early progressive out-of-bed mobilization protocol can enhance mobility and functional outcomes and shorten ICU stay and ventilation duration of patients with moderate-to-severe TBI. Our study’s results support further investigation of EPM through larger, randomized clinical trials.
Clinical trial registration ClinicalTrials.gov NCT04810273. Registered 13 March 2021.
Genetic prediction of the relationship between metabolic syndrome and colorectal cancer risk: a Mendelian randomization study
Authors: Yuan Chendong , Shu Xufeng , Hu Zhenzhen , Jie Zhigang 
Published: May 2024

Abstract
Background
Despite a growing body of observational studies indicating a potential link between metabolic syndrome and colorectal cancer, a definitive causal relationship has yet to be established. This study aimed to elucidate the causal relationship between metabolic syndrome and colorectal cancer through Mendelian randomization.

Methods
We screened for instrumental variables associated with metabolic syndrome and its diagnostic components and with colorectal cancer through the use of a genome-wide association study database, and conducted a preliminary Mendelian randomization analysis. To corroborate the dependability of our conclusions, an additional dataset was used for replication analysis in a Mendelian randomization method, which was further integrated with a meta-analysis.

Results
Preliminary analysis using the inverse variance weighted method revealed positive correlations between metabolic syndrome (OR [95% CI] = 1.37[1.15–1.63], P = 5.02 × 10–4) and waist circumference (OR [95% CI] = 1.39[1.21–1.61], P = 7.38 × 10–6) and the risk of colorectal cancer. Replication analysis also revealed the same results: metabolic syndrome (OR [95% CI] = 1.24[1.02–1.51], P = 0.030) and waist circumference (OR [95% CI] = 1.23[1.05–1.45], P = 0.013). The meta-analysis results further confirmed the associations between metabolic syndrome (OR [95% CI] = 1.31[1.15–1.49], P < 0.001) and waist circumference (OR [95% CI] = 1.32[1.18–1.47], P < 0.001) and colorectal cancer.

Conclusion
Our study indicated that metabolic syndrome increases the risk of CRC, particularly in patients with abdominal obesity.
TBX3 transfection and nodal signal pathway inhibition promote differentiation of adipose mesenchymal stem cell to cardiac pacemaker-like cells
Authors: Basalamah Faris , Dilogo Ismail Hadisoebroto , Raharjo Sunu Budhi , Mansyur Muchtaruddin , Siregar Nuryati Chairani , Ibrahim Nurhadi , Setianto Budi Yuli , Yuniadi Yoga 
Published: May 2024

Abstract
Background
Mesenchymal stem cells (MSCs) are known as one of the best candidate cells to produce cardiac pacemaker-like cells (CPLCs). Upregulation of TBX3 transcription factor and inhibition of the nodal signal pathway have a significant role in the formation of cardiac pacemaker cells such as sinoatrial and atrioventricular nodes, which initiate the heartbeat and control the rhythm of heart contractions. This study aimed to confirm the effects of transfection of TBX3 transcription factor and inhibition of the nodal signal pathway on differentiating adipose-derived MSCs (AD-MSCs) to CPLCs. AD-MSCs were characterized using flow cytometry and three-lineage differentiation staining.

Methods
The transfection of TBX3 plasmid was carried out using lipofectamine, and inhibition of the nodal signal pathway was done using the small-molecule SB431542. The morphology of the cells was observed using a light microscope. Pacemaker-specific markers, including TBX3, Cx30, HCN4, HCN1, HCN3, and KCNN4, were evaluated using the qRT-PCR method. For protein level, TBX3 and Cx30 were evaluated using ELISA and immunofluorescence staining. The electrophysiology of cells was evaluated using a patch clamp.

Results
The TBX3 expression in the TBX3, SM, and TBX + SM groups significantly higher (p < 0.05) compared to the control group and cardiomyocytes. The expression of Cx40 and Cx43 genes were lower in TBX3, SM, TBX + SM groups. In contrast, Cx30 gene showed higher expression in TBX3 group. The expression HCN1, HCN3, and HCN4 genes are higher in TBX3 group.

Conclusion
The transfection of TBX3 and inhibition of the nodal signal pathway by small-molecule SB431542 enhanced differentiation of AD-MSCs to CPLCs.
Morphology, taxonomy and trophic interactions of rostrum-less coleoids from the Late Triassic Polzberg Konservat-Lagerstätte (Lower Austria)
Authors: Lukeneder Petra , Fuchs Dirk , Lukeneder Alexander 
Published: May 2024

AbstractColeoid cephalopods are widespread from the Mesozoic till today. The extinct group of the Phragmoteuthida is thought to represent either stem-neocoleoids, stem-decabrachians, or stem-octobrachians. The well-known, almost complete specimens of Phragmoteuthis bisinuata from the Carnian Polzberg Konservat-Lagerstätte near Lunz am See (Lower Austria, Northern Calcareous Alps) and Cave del Predil (Northern Italy, Julian Alps) come from historical collections. These specimens do not reflect the entire coleoid assemblage within this environment. In order to obtain a more complete picture of the Carnian coleoid fauna, 430 coleoid specimens from the Polzberg locality and 60 specimens from contemporaneous localities around Cave del Predil were studied in detail. All available elements (phragmocones, proostraca, cartilages, hooks, beaks, ink sacs) attributed to the coleoid fauna were recorded, measured and evaluated taxonomically and taphonomically. Reviews of historical collection material permitted comparisons with recently collected material. The notation of co-occurrences of other faunal elements yielded insights into the palaeoecological context of this Upper Triassic environment within the Polzberg Basin. The new material from Polzberg does not support the previous assumption of a monospecific composition of the Polzberg coleoid fauna. Instead, we report the occurrence of the new phragmoteuthid Phragmoteuthis polzbergensis nov. sp. and a newly excavated specimen of Phragmoteuthis indicates the presence of ten arms within the group of the Phragmoteuthida for the first time. Phragmocones with small opening angles combined with cylindrical (roundly closed) body chambers, and arm hook types which are unusual for phragmoteuthids indicate the presence of the basal coleoid group comprising the rostrum-less genus Mojsisovicsteuthis.ZooBank LSID: urn:lsid:zoobank.org:pub:7EE7425C-6B0C-4800-925A-52D9108C13C7.